|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/436 | |
| A61F 2/00 | |||
| A61K 9/00 | |||
| A61K 31/453 | |||
| A61K 31/787 | |||
| A61P 9/00 | |||
| A61K 47/00 | |||
| A61L 27/34 | |||
| A61L 27/54 | |||
| A61L 29/08 | |||
| A61L 31/10 | |||
| A61L 31/16 | |||
| A61L 29/16 | |||
| A61L 31/00 | |||
| A61F 2/90 | |||
| A61F 2/92 |
| (11) | Number of the document | 2702993 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13181253.9 |
| Date of filing the European patent application | 2007-09-12 | |
| (97) | Date of publication of the European application | 2014-03-05 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 825531 P | 2006-09-13 | US |
| (72) |
Yan, John, US
Zheng, Xiaoxia, US
Bhat, Vinayak D., US
|
| (73) |
Elixir Medical Corporation,
920 N. McCarthy Boulevard, Milpitas, CA 95035,
US
|
| (54) | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE |
| MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE |